Clinical trial Recruiting at 1 site Observational Ages 70 to 89

Investigating excessive supraventricular activity and its link to atrial fibrillation

Official title: Detection of Atrial Fibrillation in Patients With Excessive Supraventricular Activity

Run by Karolinska Institutet · NCT04593498 · Data updated 2026-11-12

This study is testing whether people with extra heartbeats detected by a monitor should get more screening to find out if they have undiagnosed atrial fibrillation or flutter.

More Atrial Fibrillation trials

Quick facts

Study typeObservational
Ages70 Years to 89 Years
SexAll
Enrollment250 (estimated)
SponsorKarolinska Institutet
Academic / other
Locations1 site (Stockholm)
StatusRecruiting
StartedNovember 1, 2022
Main results expectedDecember 31, 2026
Study endsFebruary 15, 2028
Registry record updatedMarch 6, 2024
Trial IDNCT04593498 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 70 to 89 with excessive supraventricular ectopic activity as identified on Holter recordings.

Probably not a fit

Patients under 70 or over 89 years old, those with existing atrial fibrillation or flutter, or those on lifelong anticoagulant therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to determine whether individuals with excessive supraventricular ectopic activity (ESVEA) detected through Holter monitoring should undergo prolonged screening with an Event loop recorder to identify undiagnosed atrial fibrillation or flutter. The study will compare ESVEA patients with a matched control group, assessing various biomarkers, echocardiographic data, and cardiovascular health over a period of 21 months. Participants will also complete questionnaires and have blood samples collected for further analysis of potential atrial fibrillation biomarkers.

Why it matters

Potential benefit: If successful, this study could lead to earlier detection and management of atrial fibrillation, potentially reducing the risk of stroke and other complications for patients.

How similar studies have gone: Other studies have shown promising results in identifying atrial fibrillation through similar monitoring techniques, suggesting this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients with at least 30 supraventricular extra systole (SVES)/h or a supraventricular run of at least 20 beats on a Holter recording.

Exclusion Criteria:

Age \< 70 years, \>89 years Atrial fibrillation / flutter Lifelong treatment with oral anticoagulant Patients with implantable cardiac device Congestive heart failure (CHF) with Ejection fraction (EF) ≤ 30% Severe valvular heart disease

Where it's running

  • Danderyd Hospital
    Stockholm, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.